0001849296 2025-04-01 2026-03-31 0001849296 dei:BusinessContactMember 2025-04-01 2026-03-31 0001849296 2026-07-15 shares true FY 0001849296 20-F/A false true 2026-03-31 --03-31 2026 false false 001-41386 OKYO Pharma Limited Y7 OKYO Pharma Limited Martello Court Admiral Park St. Peter Port GG GY1 3HB Chief Financial Officer 107 Cheapside London EC2V 6DN GB +44 20 7495 2379 kshah@okyopharma.com 52479527 No No Yes Yes Non-accelerated Filer true false false false International Financial Reporting Standards false This Amendment No. 1 on Form 20-F/A (the “Amended Annual Report”) amends the Annual Report on Form 20-F of OKYO Pharma Limited (the “Company” or “we”) for the year ended March 31, 2026 (the “Original Form 20-F”), filed on July 20, 2026, with the Securities and Exchange Commission (the “SEC”). The only changes made to the Original Form 20-F are to revise the Exhibit Table to include the Company’s Clawback policy, which was erroneously omitted from the previous filing. Except as noted above, the Company has not modified, or updated disclosures presented in this Amended Annual Report. Accordingly, the Amended Annual Report does not reflect events occurring after the Original Form 20-F or modify or update those disclosures affected by subsequent events.